pentoxifylline has been researched along with Elevated Cholesterol in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (PTX) is an inhibitor of cytokines and PAF and would reduce the generation of ROS by granulocytes and endothelial cells." | 5.34 | Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. ( Lee, P; Prasad, K, 2007) |
| "Pentoxifylline (PTX) is an inhibitor of cytokines and PAF and would reduce the generation of ROS by granulocytes and endothelial cells." | 1.34 | Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. ( Lee, P; Prasad, K, 2007) |
| "So pentoxifylline was added to the regimen." | 1.31 | Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia. ( Abe, M; Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Matsumoto, T; Sugihara, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prasad, K | 1 |
| Lee, P | 1 |
| Angelkort, B | 1 |
| Kiesewetter, H | 1 |
| Aihara, K | 1 |
| Azuma, H | 1 |
| Ikeda, Y | 1 |
| Akaike, M | 1 |
| Abe, M | 1 |
| Sugihara, T | 1 |
| Matsumoto, T | 1 |
3 other studies available for pentoxifylline and Elevated Cholesterol
| Article | Year |
|---|---|
Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; Body Weight; Butylene Glycols; Cholesterol, Dietary; | 2007 |
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic | 1981 |
Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.
Topics: Adult; Anemia, Hemolytic; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Chelating Age | 2001 |